Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 697 | 602 | 1,610 | 2,002 | 2,887 |
| Gross Profit | 697 | 602 | 1,610 | 2,002 | 2,887 |
| Operating Expenses | 24,771 | 10,010 | 11,646 | 14,635 | 14,051 |
| Operating Income | -24,074 | -9,408 | -10,036 | -12,633 | -11,164 |
| Interest Expense | 56 | 71 | 83 | 97 | 106 |
| Other Income | 571 | 808 | 938 | 1,105 | 1,320 |
| Pre-tax Income | -23,559 | -8,671 | -9,181 | -11,625 | -9,950 |
| Net Income Continuous | -23,559 | -8,671 | -9,181 | -11,625 | -9,950 |
| Net Income | $-23,559 | $-8,671 | $-9,181 | $-11,625 | $-9,950 |
| EPS Basic Total Ops | -42.87 | -15.75 | -16.73 | -21.05 | -16.54 |
| EPS Basic Continuous Ops | -42.70 | -15.74 | -16.72 | -21.27 | -16.81 |
| EPS Diluted Total Ops | -42.87 | -15.75 | -16.73 | -21.05 | -16.54 |
| EPS Diluted Continuous Ops | -42.70 | -15.74 | -16.72 | -21.27 | -16.81 |
| EPS Diluted Before Non-Recurring Items | -42.86 | -15.79 | -16.54 | N/A | N/A |
| EBITDA(a) | $-24,065 | $-9,398 | $-10,024 | $-12,618 | $-11,214 |